Skip to search formSkip to main contentSkip to account menu

vortioxetine

Known as: 1-(2-(2,4-dimethylphenylsulfanyl)phenyl)piperazine, 4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium, vortioxetine cation 
National Institutes of Health

Related topics

Related topics

12 relations

Broader (7)

Anti-Anxiety AgentsPiperazinesSerotonin 5-HT1 Receptor AgonistsSerotonin 5-HT1 Receptor Antagonists

Narrower (3)

BrintellixLu AA21004VORTIOXETINE HYDROBROMIDE
vortioxetine 10 MG Oral Tablet [Brintellix]vortioxetine 5 MG Oral Tablet [Trintellix]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
A neuromuscular‐based analysis of the open payments program
In August 2013, the Centers for Medicare and Medicaid Services (CMS) Open Payments Program (OPP) made eligible payment… 
2019
2019
Efficacy of vortioxetine combined cognitive behaviour intervention therapy on brain‐derived neurotrophic factor level on depressive patients
To evaluate the effect of vortioxetine combined with cognitive behaviour intervention on the level of brain‐derived neurotrophic… 
2018
2018
Vortioxetine Disposition in Obesity: Potential Implications for Patient Safety
Background Obesity and depression are common comorbid conditions. The objective of the study was to evaluate the effect of… 
2018
2018
More data, more answers: picking the optimal antidepressant
Review
2018
Review
2018
Efficacy and tolerability of different doses of three new antidepressants for treating major depressive disorder: A PRISMA-compliant meta-analysis.
2018
2018
Vortioxetine overdose in a suicidal attempt
Rationale: Vortioxetine is a new multimodal antidepressant approved by the Food and Drug Administration for the treatment of… 
2018
2018
Serious dermatological adverse effects of vortioxetine: two cases
ABSTRACT In this case report, we present two patients who developed serious dermatological adverse reactions following… 
2017
2017
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland
ABSTRACT Background: To assess the cost-utility of vortioxetine versus relevant comparators (agomelatine, bupropion SR… 
2017
2017
Impact of Vortioxetine on Synaptic Integration in Prefrontal-Subcortical Circuits: Comparisons with Escitalopram
Prefrontal-subcortical circuits support executive functions which often become dysfunctional in psychiatric disorders… 
Review
2014
Review
2014
The efficacy and safety of 5 mg/d Vortioxetine compared to placebo for major depressive disorder: A meta-analysis
This meta-analysis assessed the efficacy and safety of 5 mg/day vortioxetine compared to placebo for adult major depressive… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)